Intensified Doxorubicin-Based Regimen Efficacy in Residual Non-Hodgkin's Lymphoma Disease: Towards a Computationally Supported Treatment Improvement (Q2788513)

From MaRDI portal
scientific article
Language Label Description Also known as
English
Intensified Doxorubicin-Based Regimen Efficacy in Residual Non-Hodgkin's Lymphoma Disease: Towards a Computationally Supported Treatment Improvement
scientific article

    Statements

    Intensified Doxorubicin-Based Regimen Efficacy in Residual Non-Hodgkin's Lymphoma Disease: Towards a Computationally Supported Treatment Improvement (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    19 February 2016
    0 references
    0 references
    mathematical model
    0 references
    vascular tumour
    0 references
    avascular tumour
    0 references
    heterogeneity
    0 references
    chemotherapy
    0 references
    non-Hodgkin lymphoma
    0 references
    CHOP
    0 references
    doxorubicin
    0 references
    hybrid cellular automata
    0 references
    0 references